Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells

被引:13
|
作者
Han, Shinha [1 ]
Kim, Kwanghee [1 ]
Song, Youngcheon [1 ]
Kim, Hyunyul [1 ]
Kwon, Jeunghak [1 ]
Lee, Young-Hee [2 ]
Lee, Chong-Kil [2 ]
Lee, Sang-Jin [1 ]
Ha, Namjoo [1 ]
Kim, Kyungjae [1 ]
机构
[1] Sahmyook Univ, Dept Pharm, Seoul 139742, South Korea
[2] Chungbuk Natl Univ, Coll Pharm, Chonju 360763, South Korea
关键词
auranofin; dendritic cells; cross-presentation; immunosuppression; MHC;
D O I
10.1007/s12272-001-1166-9
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Auranofin (AF), an orally administered, gold-based, anti-arthritic agent, has emerged as a clinically useful therapeutic drug for the treatment of rheumatoid arthritis. In the present study, we examined the effects of AF on major histocompatibility complex (MHC)-restricted antigen presentation in dendritic cells (DCs), which are the most important accessory cells for the induction of T cell responses. A mouse dendritic cell line, DC2.4 cells, and DCs that were generated from mouse bone marrow cells by culturing with granulocyte macrophage-colony stimulating factor (GM-CSF) and interieulkin (IL)-4 were each pretreated with AF for 2 hr, and then incubated with ovalbumin (OVA). After the 2-hr incubation, the DCs were fixed, and the amounts of OVA peptide-H-2K(b) complexes were assessed using OVA-specific CD8+ T cells. AF inhibited MHC class I-restricted presentation of exogenous OVA. This inhibitory activity of AF appeared to be due not only to the inhibition of the phagocytic activity of DCs, but also to the suppression of MHC molecule expression on DCs. AF also inhibited MHC class II-restricted presentation of exogenous OVA. These results show that AF exerts immunosuppressive activity at least in part by inhibiting MHC-restricted antigen presentation in professional antigen-presenting cells.
引用
收藏
页码:370 / 376
页数:7
相关论文
共 50 条
  • [1] Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells
    Shinha Han
    Kwanghee Kim
    Youngcheon Song
    Hyunyul Kim
    Jeunghak Kwon
    Young-Hee Lee
    Chong-Kil Lee
    Sang-Jin Lee
    Namjoo Ha
    Kyungjae Kim
    [J]. Archives of Pharmacal Research, 2008, 31 : 370 - 376
  • [2] Auranofin, immunosuppressive drug, inhibits the MHC class I and MHC class II pathway of antigen presentation in dendritic cells
    Kim, Kyungjae
    Han, Shinha
    Kim, Hyunyul
    Kim, Kwanghee
    Kwon, Jeunghak
    Lee, Chong-Kil
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 178
  • [3] Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway
    Pan, JP
    Ju, DW
    Wang, QQ
    Zhang, MH
    Xia, DJ
    Zhang, LH
    Yu, H
    Cao, XT
    [J]. IMMUNOLOGY LETTERS, 2001, 76 (03) : 153 - 161
  • [4] MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells
    J Mark Sloan
    Michael H Kershaw
    Christopher E Touloukian
    Rejean Lapointe
    Paul F Robbins
    Nicholas P Restifo
    Patrick Hwu
    [J]. Cancer Gene Therapy, 2002, 9 : 946 - 950
  • [5] MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells
    Sloan, JM
    Kershaw, M
    Lapointe, R
    Robbins, P
    Restifo, N
    Hwu, P
    [J]. FASEB JOURNAL, 2001, 15 (05): : A1202 - A1202
  • [6] MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells
    Sloan, JM
    Kershaw, MH
    Touloukian, CE
    Lapointe, R
    Robbins, PF
    Restifo, NP
    Hwu, P
    [J]. CANCER GENE THERAPY, 2002, 9 (11) : 946 - 950
  • [7] Antigen targeting to MHC class I and MHC class Ii presentation pathways of enterocytes in inflammatory bowel disease
    Büning, J
    Schmitz, M
    Hundorfean, G
    Strobel, S
    Zimmer, KP
    Gebert, A
    Ludwig, D
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A502 - A502
  • [8] Towards a systems understanding of MHC class I and MHC class II antigen presentation
    Jacques Neefjes
    Marlieke L. M. Jongsma
    Petra Paul
    Oddmund Bakke
    [J]. Nature Reviews Immunology, 2011, 11 : 823 - 836
  • [9] Towards a systems understanding of MHC class I and MHC class II antigen presentation
    Neefjes, Jacques
    Jongsma, Marlieke L. M.
    Paul, Petra
    Bakke, Oddmund
    [J]. NATURE REVIEWS IMMUNOLOGY, 2011, 11 (12) : 823 - 836
  • [10] ATGs help MHC class II, but inhibit MHC class I antigen presentation
    Loi, Monica
    Gannage, Monique
    Munz, Christian
    [J]. AUTOPHAGY, 2016, 12 (09) : 1681 - 1682